Cargando…

Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review

BACKGROUND: Hypertension is dramatically increasing in Africa with evidence of increased severity and resistance to treatment. Although angiotensin converting enzyme gene polymorphism is associated with higher prevalence of hypertension, the evidence is inconclusive on its influence on the emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengesha, Hayelom Gebrekirstos, Petrucka, Pammla, Spence, Cara, Tafesse, Tadesse Bekele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375551/
https://www.ncbi.nlm.nih.gov/pubmed/30763326
http://dx.doi.org/10.1371/journal.pone.0211054
_version_ 1783395377654792192
author Mengesha, Hayelom Gebrekirstos
Petrucka, Pammla
Spence, Cara
Tafesse, Tadesse Bekele
author_facet Mengesha, Hayelom Gebrekirstos
Petrucka, Pammla
Spence, Cara
Tafesse, Tadesse Bekele
author_sort Mengesha, Hayelom Gebrekirstos
collection PubMed
description BACKGROUND: Hypertension is dramatically increasing in Africa with evidence of increased severity and resistance to treatment. Although angiotensin converting enzyme gene polymorphism is associated with higher prevalence of hypertension, the evidence is inconclusive on its influence on the emerging pattern in Africa. This meta-analysis is conducted to pool the available evidence to inform future research and interventions. METHODS: Articles published through May 2018 were systematically searched in PubMed, Scopus and EMBASE databases. Studies were assessed for inclusion by two independent researchers. Six models were used to assess the effect of angiotensin converting enzyme deletion-insertion gene polymorphism. Heterogeneity and publication bias were tested and sensitivity analysis was carried out. Odds ratio and 95% confidence intervals were measured for pooled effect. Both random effect and fixed effect models were used, whilst the frequency of DD, II and DI genotypes were computed and compared. RESULT: Patients with D allele were 1.49 times more likely to develop essential hypertension compared with patients who carry the I allele (OR:1.49; CI:1.07, 2.07). Similarly, patients who had homozygous co-dominance genotype DD (i.e., DD vs II) were at a 2.17 times higher risk of essential hypertension compared to the co-dominant genotype II (OR:2.17, CI:1.79, 3.18), dominant model (I.e., DD+ID vs II) (OR:1.48; CI:1.03, 2.12), and recessive model (OR:1.64; CI:1.03, 2.61). On subgroup analysis, participants from Sub-Saharan Africa were more genetically susceptible to hypertension compared to their North Africa counterparts. There was no publication bias found, but there was high to moderate heterogeneity. CONCLUSION: ACE I/D polymorphism is associated with essential hypertension in Africa in the allele contrast model, as well as the dominant, recessive and homozygous codominance model. On subgroup analysis, ACE I/D was associated with essential hypertension in patients from Sub-Saharan Africa but not in North Africa. A future large scale study, which includes different ethnic groups, is recommended.
format Online
Article
Text
id pubmed-6375551
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63755512019-03-01 Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review Mengesha, Hayelom Gebrekirstos Petrucka, Pammla Spence, Cara Tafesse, Tadesse Bekele PLoS One Research Article BACKGROUND: Hypertension is dramatically increasing in Africa with evidence of increased severity and resistance to treatment. Although angiotensin converting enzyme gene polymorphism is associated with higher prevalence of hypertension, the evidence is inconclusive on its influence on the emerging pattern in Africa. This meta-analysis is conducted to pool the available evidence to inform future research and interventions. METHODS: Articles published through May 2018 were systematically searched in PubMed, Scopus and EMBASE databases. Studies were assessed for inclusion by two independent researchers. Six models were used to assess the effect of angiotensin converting enzyme deletion-insertion gene polymorphism. Heterogeneity and publication bias were tested and sensitivity analysis was carried out. Odds ratio and 95% confidence intervals were measured for pooled effect. Both random effect and fixed effect models were used, whilst the frequency of DD, II and DI genotypes were computed and compared. RESULT: Patients with D allele were 1.49 times more likely to develop essential hypertension compared with patients who carry the I allele (OR:1.49; CI:1.07, 2.07). Similarly, patients who had homozygous co-dominance genotype DD (i.e., DD vs II) were at a 2.17 times higher risk of essential hypertension compared to the co-dominant genotype II (OR:2.17, CI:1.79, 3.18), dominant model (I.e., DD+ID vs II) (OR:1.48; CI:1.03, 2.12), and recessive model (OR:1.64; CI:1.03, 2.61). On subgroup analysis, participants from Sub-Saharan Africa were more genetically susceptible to hypertension compared to their North Africa counterparts. There was no publication bias found, but there was high to moderate heterogeneity. CONCLUSION: ACE I/D polymorphism is associated with essential hypertension in Africa in the allele contrast model, as well as the dominant, recessive and homozygous codominance model. On subgroup analysis, ACE I/D was associated with essential hypertension in patients from Sub-Saharan Africa but not in North Africa. A future large scale study, which includes different ethnic groups, is recommended. Public Library of Science 2019-02-14 /pmc/articles/PMC6375551/ /pubmed/30763326 http://dx.doi.org/10.1371/journal.pone.0211054 Text en © 2019 Mengesha et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mengesha, Hayelom Gebrekirstos
Petrucka, Pammla
Spence, Cara
Tafesse, Tadesse Bekele
Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title_full Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title_fullStr Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title_full_unstemmed Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title_short Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review
title_sort effects of angiotensin converting enzyme gene polymorphism on hypertension in africa: a meta-analysis and systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375551/
https://www.ncbi.nlm.nih.gov/pubmed/30763326
http://dx.doi.org/10.1371/journal.pone.0211054
work_keys_str_mv AT mengeshahayelomgebrekirstos effectsofangiotensinconvertingenzymegenepolymorphismonhypertensioninafricaametaanalysisandsystematicreview
AT petruckapammla effectsofangiotensinconvertingenzymegenepolymorphismonhypertensioninafricaametaanalysisandsystematicreview
AT spencecara effectsofangiotensinconvertingenzymegenepolymorphismonhypertensioninafricaametaanalysisandsystematicreview
AT tafessetadessebekele effectsofangiotensinconvertingenzymegenepolymorphismonhypertensioninafricaametaanalysisandsystematicreview